Andrew Volosov in

Andrew Volosov

Vice President, Clinical Pharmacology and Preclinical R&D at Galectin Therapeutics
📍 Waban, Massachusetts, United States

Andrew Volosov serves as Vice President of Clinical Pharmacology and Pharmacokinetics at Galectin Therapeutics, bringing over two decades of experience in the pharmaceutical industry. Holding a PhD from The Hebrew University of Jerusalem, he has deep expertise in drug metabolism, pharmacokinetics, and biomarker development, having held senior roles at Premier Research, Shire, and Sepracor.

He is the co-inventor on multiple patents for novel pharmaceutical compositions and has authored or co-authored numerous peer-reviewed manuscripts and abstracts.

Read the full overview →
Experience
2 Years
Current Role
Vice President, Clinical Pharmacology and Preclinical R&D
Job Level
Senior
Location
Waban, Massachusetts, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities

Topics Andrew cares about

Clinical Pharmacology
His career focus for over 20 years, leading clinical pharmacology and preclinical R&D in his current role at Galectin Therapeutics.
Drug Development
Manages the execution of clinical pharmacology strategy, a key component in advancing new drugs through the development pipeline.
+4 more topics Login to view topics
Career

Work history

11-2025
Vice President, Clinical Pharmacology and Preclinical R&D
Galectin Therapeutics
6-2023 - 11-2025
Senior Director, Clinical Pharmacology and Preclinical Research & Development
Galectin Therapeutics
5-2023
Senior Director, Clinical Pharmacokinetics
Premier Research
Group Leader, Biomarker Development
Shire HGT
Associate Director, Drug Metabolism and Pharmacokinetics
Sepracor
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1995 - 2000
PhD
The Hebrew University of Jerusalem
Social presence
in

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Andrew. Free, 10 seconds.